Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

09 December 2021 : Database Analysis  

Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in Breast Cancer

Weiwei Yi1ABCEF, Haiqing Shen2BC, Dexi Sun3BC, Yongchao Xu4BC, Yujie Feng1BC, Dongbing Li5BC, Caixia Wang1ABCEF*

DOI: 10.12659/MSM.934522

Med Sci Monit 2021; 27:e934522

Table 2 Expression of SLC26A4-AS1 in breast cancer is associated with clinical characteristics.

CharacteristicLow expression of SLC26A4-AS1High expression of SLC26A4-AS1pStatisticMethod
n541542
T stage, n (%)0.9090.54Chisq.test
 T1140 (13%)137 (12.7%)
 T2309 (28.6%)320 (29.6%)
 T371 (6.6%)68 (6.3%)
 T419 (1.8%)16 (1.5%)
N stage, n (%)0.5362.18Chisq.test
 N0245 (23%)269 (25.3%)
 N1179 (16.8%)179 (16.8%)
 N261 (5.7%)55 (5.2%)
 N342 (3.9%)34 (3.2%)
M stage, n (%)0.8360.04Chisq.test
 M0452 (49%)450 (48.8%)
 M111 (1.2%)9 (1%)
Pathologic stage, n (%)0.7361.27Chisq.test
 Stage I87 (8.2%)94 (8.9%)
 Stage II306 (28.9%)313 (29.5%)
 Stage III123 (11.6%)119 (11.2%)
 Stage IV11 (1%)7 (0.7%)
Race, n (%)0.9450.11Chisq.test
 Asian30 (3%)30 (3%)
 Black or African American89 (9%)92 (9.3%)
 White363 (36.5%)390 (39.2%)
Age, n (%)11.49Chisq.test
 ≤60272 (25.1%)329 (30.4%)
 >60269 (24.8%)213 (19.7%)
Histological type, n (%)0.9400.01Chisq.test
 Infiltrating ductal carcinoma387 (39.6%)385 (39.4%)
 Infiltrating lobular carcinoma104 (10.6%)101 (10.3%)
PR status, n (%)Fisher.test
 Negative141 (13.6%)201 (19.4%)
 Indeterminate2 (0.2%)2 (0.2%)
 Positive375 (36.3%)313 (30.3%)
ER status, n (%)Fisher.test
 Negative89 (8.6%)151 (14.6%)
 Indeterminate1 (0.1%)1 (0.1%)
 Positive428 (41.4%)365 (35.3%)
HER2 status, n (%)0.6240.94Chisq.test
 Negative274 (37.7%)284 (39.1%)
 Indeterminate5 (0.7%)7 (1%)
 Positive71 (9.8%)86 (11.8%)
PAM50, n (%)82.17Chisq.test
 Normal7 (0.6%)33 (3%)
 LumA291 (26.9%)271 (25%)
 LumB139 (12.8%)65 (6%)
 Her248 (4.4%)34 (3.1%)
 Basal56 (5.2%)139 (12.8%)
Menopause status, n (%)0.00212.79Chisq.test
 Pre91 (9.4%)138 (14.2%)
 Peri17 (1.7%)23 (2.4%)
 Post372 (38.3%)331 (34.1%)
Anatomic neoplasm subdivisions, n (%)0.2361.4Chisq.test
 Left271 (25%)292 (27%)
 Right270 (24.9%)250 (23.1%)
Radiation therapy, n (%)0.5760.31Chisq.test
 No219 (22.2%)215 (21.8%)
 Yes268 (27.2%)285 (28.9%)
Age, median (IQR)60 (51, 69)55 (47, 65)171329Wilcoxon

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750